首页 > 最新文献

Epidemiologie Mikrobiologie Imunologie最新文献

英文 中文
Repeatedly negative PCR results in patients with COVID-19 symptoms: Do they have SARS-CoV-2 infection or not? COVID-19症状患者PCR反复阴性:他们是否感染了SARS-CoV-2 ?
IF 0.5 4区 医学 Q4 Medicine Pub Date : 2021-01-01
J Beneš, O Džupová, A Poláková, N Sojková

Objective: To point out possible infection with SARS-CoV-2 in symptomatic patients despite repeated negative nasopharyngeal swab tests for SARS-CoV-2.

Material and methods: A retrospective observational study carried out at the Na Bulovce Hospital from the beginning of the pandemic until November 2020 included patients (1) who had symptoms compatible with COVID-19; (2) whose nasopharyngeal swab PCR tests in the presence of acute respiratory infection symptoms yielded two consecutive negative results; (3) in whom SARS-CoV-2 infection was subsequently confirmed by serology. Basic demographic and epidemiological data, symptoms, laboratory test results, X-ray findings and timing of virological tests were analysed for these patients.

Results: Seventeen patients met the inclusion criteria, 14 men and three women, aged 19-84 years with a median of 59 years, of whom 14 were hospitalized and three were treated as outpatients. Only seven patients were aware of the previous contact with an infected person. The main symptoms were fever, cough, headache, weakness, fatigue and shortness of breath. Pneumonia was found in 12 patients, four of whom developed respiratory insufficiency requiring ventilatory support. Most patients showed a uniform combination of haematological, biochemical and radio-logical findings: absence of eosinophils and increased polymorphonuclear/lymphocyte ratio; elevation of serum lactate dehydrogenase; elevation of CRP without rise of procalcitonin; typical chest CT or X-ray findings. All patients recovered. Coronavirus antigen test was performed in six patients, with all of them testing negative. SARS-CoV-2 infection was confirmed serologically by the detection of specific IgG and IgA in all 17 patients and also IgM in six patients, not before day 8 of the onset of symptoms.

Conclusions: Our study showed that some patients with acute COVID-19 may test repeatedly negative by nasopharyngeal swab PCR. These cases should be interpreted as a low viral load in the upper respiratory tract rather than false negativity of PCR. Such alternative is not envisaged in the algorithms used. Considering our results, the following recommendation can be made: If, despite negative PCR tests, COVID-19 is still suspected based on clinical symptoms and epidemiological evidence, preliminary diagnosis can be made on the basis of comprehensive assessment of the laboratory test and X-ray findings. Final confirmation of the aetiology relies on serological tests performed two weeks after the onset of symptoms.

目的:探讨多次鼻咽拭子SARS-CoV-2检测阴性但仍有症状的患者感染SARS-CoV-2的可能性。材料和方法:从大流行开始到2020年11月,在Na Bulovce医院进行了一项回顾性观察性研究,纳入了以下患者:(1)有与COVID-19相一致的症状;(2)出现急性呼吸道感染症状时,鼻咽拭子PCR检测连续两次呈阴性;(3)经血清学证实为SARS-CoV-2感染者。对这些患者的基本人口和流行病学数据、症状、实验室检测结果、x光检查结果和病毒学检测时间进行了分析。结果:符合纳入标准的患者17例,男14例,女3例,年龄19 ~ 84岁,中位年龄59岁,其中住院14例,门诊3例。只有7名患者知道之前与感染者有过接触。主要症状为发热、咳嗽、头痛、乏力、乏力、气短。12例患者发现肺炎,其中4例出现呼吸功能不全,需要呼吸机支持。大多数患者的血液学、生化和放射学表现一致:嗜酸性粒细胞缺失,多形核/淋巴细胞比例增加;血清乳酸脱氢酶升高;CRP升高,但降钙素原升高;典型胸部CT或x线表现。所有患者均康复。对6例患者进行冠状病毒抗原检测,结果均为阴性。在症状出现第8天之前,所有17例患者通过检测特异性IgG和IgA以及6例患者的IgM,血清学证实了SARS-CoV-2感染。结论:我们的研究表明,部分急性COVID-19患者的鼻咽拭子PCR检测结果可能反复阴性。这些病例应解释为上呼吸道病毒载量低,而不是PCR假阴性。在使用的算法中没有考虑到这种替代方案。考虑到我们的结果,建议如下:如果根据临床症状和流行病学证据仍怀疑为COVID-19,可根据实验室检查和x线检查的综合评估作出初步诊断。病因的最终确认依赖于症状出现两周后进行的血清学检测。
{"title":"Repeatedly negative PCR results in patients with COVID-19 symptoms: Do they have SARS-CoV-2 infection or not?","authors":"J Beneš,&nbsp;O Džupová,&nbsp;A Poláková,&nbsp;N Sojková","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To point out possible infection with SARS-CoV-2 in symptomatic patients despite repeated negative nasopharyngeal swab tests for SARS-CoV-2.</p><p><strong>Material and methods: </strong>A retrospective observational study carried out at the Na Bulovce Hospital from the beginning of the pandemic until November 2020 included patients (1) who had symptoms compatible with COVID-19; (2) whose nasopharyngeal swab PCR tests in the presence of acute respiratory infection symptoms yielded two consecutive negative results; (3) in whom SARS-CoV-2 infection was subsequently confirmed by serology. Basic demographic and epidemiological data, symptoms, laboratory test results, X-ray findings and timing of virological tests were analysed for these patients.</p><p><strong>Results: </strong>Seventeen patients met the inclusion criteria, 14 men and three women, aged 19-84 years with a median of 59 years, of whom 14 were hospitalized and three were treated as outpatients. Only seven patients were aware of the previous contact with an infected person. The main symptoms were fever, cough, headache, weakness, fatigue and shortness of breath. Pneumonia was found in 12 patients, four of whom developed respiratory insufficiency requiring ventilatory support. Most patients showed a uniform combination of haematological, biochemical and radio-logical findings: absence of eosinophils and increased polymorphonuclear/lymphocyte ratio; elevation of serum lactate dehydrogenase; elevation of CRP without rise of procalcitonin; typical chest CT or X-ray findings. All patients recovered. Coronavirus antigen test was performed in six patients, with all of them testing negative. SARS-CoV-2 infection was confirmed serologically by the detection of specific IgG and IgA in all 17 patients and also IgM in six patients, not before day 8 of the onset of symptoms.</p><p><strong>Conclusions: </strong>Our study showed that some patients with acute COVID-19 may test repeatedly negative by nasopharyngeal swab PCR. These cases should be interpreted as a low viral load in the upper respiratory tract rather than false negativity of PCR. Such alternative is not envisaged in the algorithms used. Considering our results, the following recommendation can be made: If, despite negative PCR tests, COVID-19 is still suspected based on clinical symptoms and epidemiological evidence, preliminary diagnosis can be made on the basis of comprehensive assessment of the laboratory test and X-ray findings. Final confirmation of the aetiology relies on serological tests performed two weeks after the onset of symptoms.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"70 1","pages":"3-9"},"PeriodicalIF":0.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25588846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pre-booster and post-booster seroprevalence of measles antibodies among employees of the Olomouc University Hospital - a pilot study. 奥洛穆茨大学医院雇员麻疹抗体增强前和增强后血清阳性率的初步研究。
IF 0.5 4区 医学 Q4 Medicine Pub Date : 2021-01-01
Štěpánek, R Večeřová, P Sauer, Štěpánek, M Kolář, M Nakládalová

Introduction: The increase in measles cases in early 2019 led to the implementation of several preventive measures focused mainly on health care providers. The study aimed to evaluate the seroprevalence of measles antibodies among employees of a large hospital and, a year apart, the rate of seroconversion in a pilot sample of the revaccinated subjects.

Methods: In 3027 employees of the University Hospital Olomouc, specific immunoglobulin G levels were tested on a voluntary basis. Those with insufficient levels were offered a booster dose. About approximately one year after the booster dose, the same test was performed in a sample of 52 employees.

Results: Of the tested subjects with a mean age of 41.8 ± 9.2 years, 54.0% were seropositive. A higher proportion of seropositivity as well as higher absolute values of antibody titers were noted in those born before routine vaccination was introduced in 1969. A total of 80.9% of the seronegative subjects opted for a booster dose. Seroconversion occurred in 73.2% of retested subjects. The relative increase of post-booster antibody titers was moderately correlated with age (r = 0.47, p < 0.05).

Conclusion: The proportion of seronegative employees of a large hospital reached 46.0%, being higher in younger individuals. Seroconversion occurred in 73.2% of booster dose recipients included in a pilot sample for reanalysis. A statistically significant correlation was noted between the relative increase of antibody titers and age.

导言:2019年初麻疹病例的增加导致实施了几项主要针对卫生保健提供者的预防措施。该研究旨在评估一家大医院员工的麻疹抗体血清阳性率,并在相隔一年的时间里,评估重新接种疫苗的试点样本的血清转换率。方法:对奥洛穆茨大学医院3027名员工进行自愿特异性免疫球蛋白G水平检测。而那些体内毒素不足的人则被注射了一剂加强剂。大约一年后,在52名雇员的样本中进行了同样的测试。结果:平均年龄(41.8±9.2)岁,血清阳性率为54.0%。在1969年引入常规疫苗接种之前出生的人血清阳性比例较高,抗体滴度绝对值也较高。总共80.9%的血清阴性受试者选择了加强剂量。73.2%的复测者发生血清转化。增强后抗体滴度的相对升高与年龄呈正相关(r = 0.47, p <0.05)。结论:某大型医院员工血清阴性比例达46.0%,以低龄人群居多。在再分析的试点样本中,73.2%的加强剂量接受者发生血清转化。抗体滴度的相对升高与年龄有统计学意义的相关性。
{"title":"Pre-booster and post-booster seroprevalence of measles antibodies among employees of the Olomouc University Hospital - a pilot study.","authors":"Štěpánek,&nbsp;R Večeřová,&nbsp;P Sauer,&nbsp;Štěpánek,&nbsp;M Kolář,&nbsp;M Nakládalová","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>The increase in measles cases in early 2019 led to the implementation of several preventive measures focused mainly on health care providers. The study aimed to evaluate the seroprevalence of measles antibodies among employees of a large hospital and, a year apart, the rate of seroconversion in a pilot sample of the revaccinated subjects.</p><p><strong>Methods: </strong>In 3027 employees of the University Hospital Olomouc, specific immunoglobulin G levels were tested on a voluntary basis. Those with insufficient levels were offered a booster dose. About approximately one year after the booster dose, the same test was performed in a sample of 52 employees.</p><p><strong>Results: </strong>Of the tested subjects with a mean age of 41.8 ± 9.2 years, 54.0% were seropositive. A higher proportion of seropositivity as well as higher absolute values of antibody titers were noted in those born before routine vaccination was introduced in 1969. A total of 80.9% of the seronegative subjects opted for a booster dose. Seroconversion occurred in 73.2% of retested subjects. The relative increase of post-booster antibody titers was moderately correlated with age (r = 0.47, p &lt; 0.05).</p><p><strong>Conclusion: </strong>The proportion of seronegative employees of a large hospital reached 46.0%, being higher in younger individuals. Seroconversion occurred in 73.2% of booster dose recipients included in a pilot sample for reanalysis. A statistically significant correlation was noted between the relative increase of antibody titers and age.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"70 2","pages":"104-109"},"PeriodicalIF":0.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39326986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of tuberculosis diagnostic tools, with extending MODS assay use to second line susceptibility testing. 评估结核病诊断工具,将MODS试验扩展到二线药敏试验。
IF 0.5 4区 医学 Q4 Medicine Pub Date : 2021-01-01
S Amer, A El Hefnawy, A Baz, H Okasha

Tuberculosis diagnosis and drug susceptibility testing (DST) are considered a priority for prompt initiation of effective therapy, increasing the chance of cure, decreasing the development of resistance, and reducing transmission.

Aim: Our objective was to evaluate currently applied diagnostic tools for tuberculosis including microscopic examination, GeneXpert, culture, and microscopic observation drug susceptibility (MODS) assay, investigating MODS assay usage for second line DST against culture based methods.

Material and methods: In this study the 120 sputum samples collected from suspected cases were over one year duration from December 2018 to January 2020. The samples were subjected to ZN microscopic examination, GeneXpert, MODS assay, and culture for detection of mycobacteria. Moreover, resistance to 5 drugs: isoniazid, rifampicin, ofloxacin, levofloxacin, and amikacin were tested using MODS against the proportion method.

Results: The sensitivity and specificity of the MODS assay were similar culture method with the advantage of obtaining the results in a median time of 10.7 days. Whereas the specificity of ZN and GeneXpert was high among untreated cases and decreased in subjects with a history of treatment. Monoresistance was the most common form of resistance detected among new cases followed by multidrug resistance, with a categorical agreement between the two methods above 90% for all tested drugs.

Conclusions: MODS assay is an attractive option once standardized for second line susceptibility testing and GeneXpert assay is of high sensitivity for rapid detection of MTB and RIF resistance especially in treatment naive cases.

结核病诊断和药敏试验(DST)被认为是迅速开始有效治疗、增加治愈机会、减少耐药性发展和减少传播的优先事项。目的:我们的目的是评估目前应用的结核病诊断工具,包括显微镜检查,GeneXpert,培养和显微镜观察药物敏感性(MODS)测定,调查MODS测定在二线DST与培养方法的使用情况。材料与方法:本研究从2018年12月至2020年1月收集了120份疑似病例的痰样本,时间超过一年。样品经ZN镜检、GeneXpert、MODS检测和分枝杆菌培养检测。采用MODS对比例法检测异烟肼、利福平、氧氟沙星、左氧氟沙星、阿米卡星5种药物的耐药性。结果:MODS检测的灵敏度和特异性与培养法相近,平均时间为10.7 d。而ZN和GeneXpert的特异性在未经治疗的病例中较高,而在有治疗史的受试者中较低。单药耐药是新发病例中发现的最常见的耐药形式,其次是多药耐药,两种方法对所有测试药物的分类一致性在90%以上。结论:MODS法是一种有吸引力的二线药敏检测方法,GeneXpert法在快速检测MTB和RIF耐药方面具有很高的灵敏度,特别是在首次治疗的病例中。
{"title":"Evaluation of tuberculosis diagnostic tools, with extending MODS assay use to second line susceptibility testing.","authors":"S Amer,&nbsp;A El Hefnawy,&nbsp;A Baz,&nbsp;H Okasha","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Tuberculosis diagnosis and drug susceptibility testing (DST) are considered a priority for prompt initiation of effective therapy, increasing the chance of cure, decreasing the development of resistance, and reducing transmission.</p><p><strong>Aim: </strong>Our objective was to evaluate currently applied diagnostic tools for tuberculosis including microscopic examination, GeneXpert, culture, and microscopic observation drug susceptibility (MODS) assay, investigating MODS assay usage for second line DST against culture based methods.</p><p><strong>Material and methods: </strong>In this study the 120 sputum samples collected from suspected cases were over one year duration from December 2018 to January 2020. The samples were subjected to ZN microscopic examination, GeneXpert, MODS assay, and culture for detection of mycobacteria. Moreover, resistance to 5 drugs: isoniazid, rifampicin, ofloxacin, levofloxacin, and amikacin were tested using MODS against the proportion method.</p><p><strong>Results: </strong>The sensitivity and specificity of the MODS assay were similar culture method with the advantage of obtaining the results in a median time of 10.7 days. Whereas the specificity of ZN and GeneXpert was high among untreated cases and decreased in subjects with a history of treatment. Monoresistance was the most common form of resistance detected among new cases followed by multidrug resistance, with a categorical agreement between the two methods above 90% for all tested drugs.</p><p><strong>Conclusions: </strong>MODS assay is an attractive option once standardized for second line susceptibility testing and GeneXpert assay is of high sensitivity for rapid detection of MTB and RIF resistance especially in treatment naive cases.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"70 3","pages":"161-167"},"PeriodicalIF":0.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39512000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Monitoring influenza virus oseltamivir resistance - our experience to date. 监测流感病毒对奥司他韦的耐药性——我们迄今的经验。
IF 0.5 4区 医学 Q4 Medicine Pub Date : 2021-01-01
L Nováková, M Havlíčková

Objective: The monitoring of influenza virus resistance is a routine part of influenza virus surveillance conducted by the National Reference Laboratory for Influenza and Non-Influenza Respiratory Viral Diseases (NRL/INI) at the National Institute of Public Health (NIPH). The aim is to detect neuraminidase inhibitor (oseltamivir) resistance in patients diagnosed with influenza.

Material and methods: A total of 326 influenza virus isolates from tissue culture were included in the study. They were obtained from inpatient and outpatient nasopharyngeal swabs which were referred to the NRL/INI during the seasons 2013/2014 to 2019/2020 and turned out to be RTPCR (reverse transcription polymerase chain reaction) positive for RNA (ribonucleic acid) of influenza virus A or B. The MDCK (Madin-Darby canine kidney) tissue culture cells were used for virus isolation from nasopharyngeal swabs. Oseltamivir resistance was tested using the NA-Star Influenza Neuraminidase Inhibitor Resistance Detection Kit (Applied Biosystems, Foster City, CA).

Results: Nine of 326 positive specimens were oseltamivir resistant. Resistant strains showed IC50 values 100 times as high on average as those in oseltamivir sensitive strains.

Conclusions: Monitoring influenza virus resistance is helpful in controlling reasonable prescription of antivirals and thus becomes an integral part of influenza virus surveillance. Antiviral resistance monitoring is necessary not only in hospitalized patients on antivirals but also in symptomatically treated outpatients as the detection of antiviral drug resistant strains in the latter group can suggest the emergence and/or spread of antiviral drug resistance in the population.

目的:流感病毒耐药性监测是国家公共卫生研究所(NIPH)流感和非流感呼吸道病毒疾病国家参考实验室(NRL/INI)开展的流感病毒监测的常规组成部分。目的是检测诊断为流感的患者对神经氨酸酶抑制剂(奥司他韦)的耐药性。材料和方法:从组织培养中分离出326株流感病毒。从2013/2014年至2019/2020年期间提交NRL/INI的住院和门诊鼻咽拭子中获得流感病毒A或b的RNA(核糖核酸)逆转录聚合酶链反应(RTPCR)阳性。采用MDCK (Madin-Darby犬肾)组织培养细胞从鼻咽拭子中分离病毒。使用NA-Star流感神经氨酸酶抑制剂耐药性检测试剂盒(应用生物系统公司,福斯特城,CA)检测奥司他韦耐药性。结果:326例阳性标本中9例对奥司他韦耐药。耐药菌株的IC50值比奥司他韦敏感菌株平均高100倍。结论:流感病毒耐药性监测有助于控制合理的抗病毒药物处方,成为流感病毒监测的重要组成部分。抗病毒药物耐药性监测不仅对接受抗病毒药物治疗的住院患者有必要,而且对对症治疗的门诊患者也有必要,因为在后者中检测到抗病毒药物耐药菌株可以提示人群中出现和/或传播抗病毒药物耐药。
{"title":"Monitoring influenza virus oseltamivir resistance - our experience to date.","authors":"L Nováková,&nbsp;M Havlíčková","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>The monitoring of influenza virus resistance is a routine part of influenza virus surveillance conducted by the National Reference Laboratory for Influenza and Non-Influenza Respiratory Viral Diseases (NRL/INI) at the National Institute of Public Health (NIPH). The aim is to detect neuraminidase inhibitor (oseltamivir) resistance in patients diagnosed with influenza.</p><p><strong>Material and methods: </strong>A total of 326 influenza virus isolates from tissue culture were included in the study. They were obtained from inpatient and outpatient nasopharyngeal swabs which were referred to the NRL/INI during the seasons 2013/2014 to 2019/2020 and turned out to be RTPCR (reverse transcription polymerase chain reaction) positive for RNA (ribonucleic acid) of influenza virus A or B. The MDCK (Madin-Darby canine kidney) tissue culture cells were used for virus isolation from nasopharyngeal swabs. Oseltamivir resistance was tested using the NA-Star Influenza Neuraminidase Inhibitor Resistance Detection Kit (Applied Biosystems, Foster City, CA).</p><p><strong>Results: </strong>Nine of 326 positive specimens were oseltamivir resistant. Resistant strains showed IC50 values 100 times as high on average as those in oseltamivir sensitive strains.</p><p><strong>Conclusions: </strong>Monitoring influenza virus resistance is helpful in controlling reasonable prescription of antivirals and thus becomes an integral part of influenza virus surveillance. Antiviral resistance monitoring is necessary not only in hospitalized patients on antivirals but also in symptomatically treated outpatients as the detection of antiviral drug resistant strains in the latter group can suggest the emergence and/or spread of antiviral drug resistance in the population.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"70 4","pages":"241-246"},"PeriodicalIF":0.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39856556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Listeriosis - an analysis of human cases in the Czech Republic in 2008-2018. 李斯特菌病——2008-2018年捷克共和国人间病例分析。
IF 0.5 4区 医学 Q4 Medicine Pub Date : 2021-01-01
M Špačková, M Gašpárek, F Stejskal

Aim: The aim of our work was to summarize the most important knowledge about listeriosis in humans and to analyse available epidemiological data on this disease in the Czech Republic in 2008-2018.

Methods: We conducted a literature search and descriptive epidemiological analysis of all human Listeria cases reported to the national surveillance system of infectious diseases (EpiDat until 2017, ISIN for 2018) in the Czech Republic in 2008-2018. For data management and analysis, MS Excel 2010 was used. The incidence maps were created using the ECDC Map Maker tool (EMMa).

Results: In total, 380 cases of human listeriosis (mean annual incidence of 0.33/100 000 inhabitants) were reported in the Czech Republic in 2008-2018. The highest age specific incidence was detected in 0-year-olds (1.85/100 000) and then in persons over 60 years (mean incidence of 0.95/100 000). Altogether 222 cases were detected in men (mean incidence of 0.39/100 000) and 158 in women (mean incidence of 0.27/100 000). Geographically, the highest mean annual incidence was reported in the Moravian-Silesian Region (0.6/100 000) and Pilsen Region (0.57/100 000). As many as 96.3% of the reported cases required hospital admission. Of 81 deaths related to listeriosis, 50 were directly caused by listeriosis. The highest monthly incidence was observed in June through October and then in January.  The incidence of listeriosis in the CZ shows an oscillating trend over the last 11 years. Neither epidemics nor imported cases were reported to the national surveillance system during the study period.

Conclusions: Listeriosis cases have been on the rise in the European Union (EU) over the last years, while in the CZ, an oscillating and slightly increasing trend has been observed. Generally, cases are reported mostly in the population aged over 64 years (and especially after the age of 84). As there is no vaccine available yet against this disease, the only option is the prevention, i.e., health education of consumers in general and of the risk groups in particular, and compliance with food safety and hygiene standards in food production and handling.

目的:我们的工作目的是总结有关人类李斯特菌病的最重要知识,并分析2008-2018年捷克共和国关于该疾病的现有流行病学数据。方法:对2008-2018年捷克共和国国家传染病监测系统(EpiDat至2017年,ISIN为2018年)报告的所有人类李斯特菌病例进行文献检索和描述性流行病学分析。数据管理和分析使用MS Excel 2010。发生率图使用ECDC地图制作工具(EMMa)创建。结果:2008-2018年,捷克共和国共报告了380例人类李斯特菌病(平均年发病率为0.33/10万居民)。年龄特异性发病率最高的是0岁儿童(1.85/10万),其次是60岁以上人群(平均发病率0.95/10万)。男性222例(平均发病率0.39/10万),女性158例(平均发病率0.27/10万)。从地理上看,平均年发病率最高的是摩拉维亚-西里西亚地区(0.6/10万)和皮尔森地区(0.57/10万)。多达96.3%的报告病例需要住院治疗。在与李斯特菌病有关的81例死亡中,有50例是直接由李斯特菌病引起的。月发病率最高的是6月至10月,然后是1月。在过去11年中,CZ的李斯特菌病发病率呈现振荡趋势。在研究期间,没有向国家监测系统报告流行病和输入病例。结论:在过去几年里,李斯特菌病病例在欧盟呈上升趋势,而在CZ,观察到一个振荡和略有增加的趋势。一般来说,病例报告主要发生在64岁以上的人群中(特别是84岁以后)。由于目前还没有针对这种疾病的疫苗,唯一的选择是预防,即对一般消费者,特别是危险群体进行健康教育,并在食品生产和处理过程中遵守食品安全和卫生标准。
{"title":"Listeriosis - an analysis of human cases in the Czech Republic in 2008-2018.","authors":"M Špačková,&nbsp;M Gašpárek,&nbsp;F Stejskal","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Aim: </strong>The aim of our work was to summarize the most important knowledge about listeriosis in humans and to analyse available epidemiological data on this disease in the Czech Republic in 2008-2018.</p><p><strong>Methods: </strong>We conducted a literature search and descriptive epidemiological analysis of all human Listeria cases reported to the national surveillance system of infectious diseases (EpiDat until 2017, ISIN for 2018) in the Czech Republic in 2008-2018. For data management and analysis, MS Excel 2010 was used. The incidence maps were created using the ECDC Map Maker tool (EMMa).</p><p><strong>Results: </strong>In total, 380 cases of human listeriosis (mean annual incidence of 0.33/100 000 inhabitants) were reported in the Czech Republic in 2008-2018. The highest age specific incidence was detected in 0-year-olds (1.85/100 000) and then in persons over 60 years (mean incidence of 0.95/100 000). Altogether 222 cases were detected in men (mean incidence of 0.39/100 000) and 158 in women (mean incidence of 0.27/100 000). Geographically, the highest mean annual incidence was reported in the Moravian-Silesian Region (0.6/100 000) and Pilsen Region (0.57/100 000). As many as 96.3% of the reported cases required hospital admission. Of 81 deaths related to listeriosis, 50 were directly caused by listeriosis. The highest monthly incidence was observed in June through October and then in January.  The incidence of listeriosis in the CZ shows an oscillating trend over the last 11 years. Neither epidemics nor imported cases were reported to the national surveillance system during the study period.</p><p><strong>Conclusions: </strong>Listeriosis cases have been on the rise in the European Union (EU) over the last years, while in the CZ, an oscillating and slightly increasing trend has been observed. Generally, cases are reported mostly in the population aged over 64 years (and especially after the age of 84). As there is no vaccine available yet against this disease, the only option is the prevention, i.e., health education of consumers in general and of the risk groups in particular, and compliance with food safety and hygiene standards in food production and handling.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"70 1","pages":"42-51"},"PeriodicalIF":0.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25588851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and management of arterial hypertension in the population aged 25-64 in the Czech Republic with a focus on diabetic patients. 捷克共和国25-64岁人群动脉高血压的患病率和管理,重点是糖尿病患者。
IF 0.5 4区 医学 Q4 Medicine Pub Date : 2021-01-01
V Vejtasová, M Lustigová, J Urbanová, K Žejglicová, J Malinovská, D Janíčková Žďárská, L Brunerová, K Kučera, J Brož

Objective: The aim of the study was to determine the prevalence of arterial hypertension and its awareness rate and control rate among diabetes mellitus (DM) patients in the Czech Republic between 25-64 years of age and to compare the results with those in age-matched non-diabetic patients.

Materials and methods: Blood pressure measurement data of 1 170 respondents (467 men and 703 women) obtained during the EHES study in 2014 were analysed. DM was diagnosed in 95 (8.2%) respondents (44 men and 51 women).

Results: Mean systolic blood pressure in DM patients was 130.7 ± 18.3 vs. 123.2 ± 16.8 mmHg in non-DM subjects (p < 0.001). The difference in diastolic blood pressure was on the borderline of statistical significance (82.2 ± 9.4 mmHg in DM vs. 80.0 ± 10.6 mmHg in non-DM subjects, p = 0.051). Among the study population, 69.5% of DM and 34.2% of non-DM subjects suffered from arterial hypertension (p < 0.001). The hypertension awareness rates were 87.9% in the DM group and 66.8 % in the non-DM group. (p = 0.001). The percentage of treated arterial hypertension was 94.8% in DM patients vs. 80.5% in the non-DM group (p = 0.010). The blood pressure target of < 140/90 mmHg was achieved in 47.3% of DM patients vs. 60.6% in non-DM subjects (p = 0.077). Using a blood pressure target of < 130/80 mmHg, adequate arterial hypertension control was achieved in only 29.1% of DM patients. When comparing the achievement of the blood pressure targets recommended for diabetic patients (< 130/80 mmHg) and non-DM patients (< 140/90 mmHg), the difference between these groups was statistically significant (p < 0.001) in favour of the non-diabetic group.

Conclusion: The study has shown the prevalence of arterial hypertension to be twice as high in DM patients aged 25-64 compared to the age-matched non-DM subjects in the Czech Republic. The adequate blood pressure control rate is significantly lower in DM patients than in the non-diabetic population. The study results indicate that the blood pressure targets recommended for diabetic patients (< 130/80 mmHg) are not always reached in clinical practice.

目的:了解捷克25-64岁糖尿病(DM)患者动脉高血压的患病率、知晓率和控制率,并与年龄匹配的非糖尿病患者进行比较。材料与方法:对2014年EHES研究中获得的1170名调查对象(男性467人,女性703人)血压测量数据进行分析。95名(8.2%)受访者(44名男性和51名女性)被诊断为糖尿病。结果:糖尿病患者平均收缩压为130.7±18.3 mmHg,非糖尿病患者为123.2±16.8 mmHg (p <0.001)。两组舒张压差异处于有统计学意义的边缘(糖尿病组82.2±9.4 mmHg vs非糖尿病组80.0±10.6 mmHg, p = 0.051)。在研究人群中,69.5%的糖尿病患者和34.2%的非糖尿病患者患有动脉高血压(p <0.001)。糖尿病组高血压知晓率为87.9%,非糖尿病组为66.8%。(p = 0.001)。糖尿病组动脉高血压治疗百分比为94.8%,非糖尿病组为80.5% (p = 0.010)。血压目标:糖尿病患者达到140/90 mmHg的比例为47.3%,非糖尿病患者为60.6% (p = 0.077)。使用血压目标为<130/80 mmHg,只有29.1%的糖尿病患者达到了适当的动脉高血压控制。当比较糖尿病患者推荐血压指标的实现情况(<130/80 mmHg)和非糖尿病患者(<140/90 mmHg),两组间差异有统计学意义(p <0.001),有利于非糖尿病组。结论:该研究表明,捷克共和国25-64岁糖尿病患者的动脉高血压患病率是年龄匹配的非糖尿病患者的两倍。糖尿病患者的适当血压控制率明显低于非糖尿病人群。研究结果提示,糖尿病患者推荐的血压指标(<130/80 mmHg)在临床实践中并不总是达到。
{"title":"Prevalence and management of arterial hypertension in the population aged 25-64 in the Czech Republic with a focus on diabetic patients.","authors":"V Vejtasová,&nbsp;M Lustigová,&nbsp;J Urbanová,&nbsp;K Žejglicová,&nbsp;J Malinovská,&nbsp;D Janíčková Žďárská,&nbsp;L Brunerová,&nbsp;K Kučera,&nbsp;J Brož","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>The aim of the study was to determine the prevalence of arterial hypertension and its awareness rate and control rate among diabetes mellitus (DM) patients in the Czech Republic between 25-64 years of age and to compare the results with those in age-matched non-diabetic patients.</p><p><strong>Materials and methods: </strong>Blood pressure measurement data of 1 170 respondents (467 men and 703 women) obtained during the EHES study in 2014 were analysed. DM was diagnosed in 95 (8.2%) respondents (44 men and 51 women).</p><p><strong>Results: </strong>Mean systolic blood pressure in DM patients was 130.7 ± 18.3 vs. 123.2 ± 16.8 mmHg in non-DM subjects (p &lt; 0.001). The difference in diastolic blood pressure was on the borderline of statistical significance (82.2 ± 9.4 mmHg in DM vs. 80.0 ± 10.6 mmHg in non-DM subjects, p = 0.051). Among the study population, 69.5% of DM and 34.2% of non-DM subjects suffered from arterial hypertension (p &lt; 0.001). The hypertension awareness rates were 87.9% in the DM group and 66.8 % in the non-DM group. (p = 0.001). The percentage of treated arterial hypertension was 94.8% in DM patients vs. 80.5% in the non-DM group (p = 0.010). The blood pressure target of &lt; 140/90 mmHg was achieved in 47.3% of DM patients vs. 60.6% in non-DM subjects (p = 0.077). Using a blood pressure target of &lt; 130/80 mmHg, adequate arterial hypertension control was achieved in only 29.1% of DM patients. When comparing the achievement of the blood pressure targets recommended for diabetic patients (&lt; 130/80 mmHg) and non-DM patients (&lt; 140/90 mmHg), the difference between these groups was statistically significant (p &lt; 0.001) in favour of the non-diabetic group.</p><p><strong>Conclusion: </strong>The study has shown the prevalence of arterial hypertension to be twice as high in DM patients aged 25-64 compared to the age-matched non-DM subjects in the Czech Republic. The adequate blood pressure control rate is significantly lower in DM patients than in the non-diabetic population. The study results indicate that the blood pressure targets recommended for diabetic patients (&lt; 130/80 mmHg) are not always reached in clinical practice.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"70 4","pages":"247-252"},"PeriodicalIF":0.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39856557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Substance use and addictive behaviours during COVID-19 confinement measures increased in intensive users: Results of an online general population survey in the Czech Republic. 在COVID-19隔离措施期间,密集使用者的物质使用和成瘾行为有所增加:捷克共和国在线一般人口调查结果。
IF 0.5 4区 医学 Q4 Medicine Pub Date : 2021-01-01
V Mravčík, P Chomynová

Background: The COVID-19 pandemic has affected substance use and other addictive behaviour, however detailed insight is lacking.

Material and methods: Online questionnaire survey on the sample of 3,000 respondents aged 15+ randomly selected from the Czech internet panel using socio-demographic quotas was performed shortly after the end of confinement measures in May 2020 (response rate 35.4%). Questions covered current prevalence and patterns of substance use (i.e. in the last 12 months) and other forms of addictive behaviours as well as changes in their behaviour during the confinement measures. Responses were provided on categorical scale; a factor of 0 to 2 was assigned to the categories to quantify the changes where 1 means no change.

Results: Respondents reporting the highest frequency of current use, especially the use of alcohol, cannabis and sedatives, further increased their intensity of use during the confinement measures by 5-10% on average, while less frequent users reduced it. The reduction of use during confinement measures increased with decreasing frequency of current use. Although the same correlation exists in tobacco smokers, decrease in intensity of use was observed also in daily smokers. On the population level, our results suggest a slight increase in total alcohol and sedatives consumption and a significant increase in the total consumption of gaming and social media. On the contrary, there was a significant reduction in the consumption of tobacco and online gambling (likely due to the ban on sports matches), and a slight reduction in the consumption of cannabis and other illicit drugs.

Conclusion: People with intensive patterns of substance use increased their use during confinement measures. The same concerns gaming and social media. Without this insight the overall picture suggests rather overall reduction of consumption. Addiction treatment system should prepare for the increase of treatment demand following COVID-19 epidemic.

背景:COVID-19大流行影响了药物使用和其他成瘾行为,但缺乏详细的了解。材料和方法:在2020年5月限制措施结束后不久,使用社会人口指标对从捷克互联网小组随机抽取的3000名15岁以上受访者进行了在线问卷调查(回复率35.4%)。问题包括目前药物使用的流行程度和模式(即过去12个月)和其他形式的成瘾行为,以及他们在禁闭措施期间的行为变化。回答以分类量表提供;将0到2的因子分配给这些类别以量化变化,其中1表示没有变化。结果:报告目前使用频率最高的答复者,特别是使用酒精、大麻和镇静剂的答复者,在禁闭措施期间的使用强度平均进一步增加了5-10%,而使用频率较低的答复者则减少了使用强度。在限制措施期间,减少的使用量随着当前使用频率的降低而增加。尽管吸烟人群中也存在同样的相关性,但在日常吸烟者中也观察到使用强度的降低。在人口水平上,我们的研究结果表明,酒精和镇静剂的总消费量略有增加,游戏和社交媒体的总消费量显著增加。相反,烟草消费和在线赌博大幅减少(可能是由于禁止体育比赛),大麻和其他非法药物的消费略有减少。结论:重度药物使用人群在禁闭期间的药物使用增加。游戏和社交媒体也是如此。如果没有这种洞见,总体情况表明消费在总体上是减少的。成瘾治疗系统应做好应对COVID-19疫情后治疗需求增加的准备。
{"title":"Substance use and addictive behaviours during COVID-19 confinement measures increased in intensive users: Results of an online general population survey in the Czech Republic.","authors":"V Mravčík,&nbsp;P Chomynová","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The COVID-19 pandemic has affected substance use and other addictive behaviour, however detailed insight is lacking.</p><p><strong>Material and methods: </strong>Online questionnaire survey on the sample of 3,000 respondents aged 15+ randomly selected from the Czech internet panel using socio-demographic quotas was performed shortly after the end of confinement measures in May 2020 (response rate 35.4%). Questions covered current prevalence and patterns of substance use (i.e. in the last 12 months) and other forms of addictive behaviours as well as changes in their behaviour during the confinement measures. Responses were provided on categorical scale; a factor of 0 to 2 was assigned to the categories to quantify the changes where 1 means no change.</p><p><strong>Results: </strong>Respondents reporting the highest frequency of current use, especially the use of alcohol, cannabis and sedatives, further increased their intensity of use during the confinement measures by 5-10% on average, while less frequent users reduced it. The reduction of use during confinement measures increased with decreasing frequency of current use. Although the same correlation exists in tobacco smokers, decrease in intensity of use was observed also in daily smokers. On the population level, our results suggest a slight increase in total alcohol and sedatives consumption and a significant increase in the total consumption of gaming and social media. On the contrary, there was a significant reduction in the consumption of tobacco and online gambling (likely due to the ban on sports matches), and a slight reduction in the consumption of cannabis and other illicit drugs.</p><p><strong>Conclusion: </strong>People with intensive patterns of substance use increased their use during confinement measures. The same concerns gaming and social media. Without this insight the overall picture suggests rather overall reduction of consumption. Addiction treatment system should prepare for the increase of treatment demand following COVID-19 epidemic.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"70 2","pages":"98-103"},"PeriodicalIF":0.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39326985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Population analysis of Streptococcus pneumoniae serotype 19A by whole genome sequencing in the Czech Republic and in Europe after serotype 19A inclusion in pneumococcal conjugate vaccine. 肺炎球菌结合疫苗中包含血清型19A后,捷克共和国和欧洲肺炎链球菌血清型19A的全基因组测序人群分析
IF 0.5 4区 医学 Q4 Medicine Pub Date : 2021-01-01
J Kozáková, Z Okonji, M Honskus

Aim: To present the results of whole genome sequencing (WGS) analysis of Streptococcus pneumoniae serotype 19A and to compare them with the respective data from Europe. The vaccine serotype 19A is widely distributed in the Czech Republic.

Material and methods: WGS was used in this study as the most powerful available method for detailed characterization of S. pneumoniae. Nineteen Czech isolates of S. pneumoniae 19A were analysed and compared with 415 European isolates included in the PubMLST database.

Results: S. pneumoniae serotype 19A causes all types of pathogen - host interaction, from carriage to noninvasive and invasive pneumococcal disease (IPD). In 2010 - 2019, 3872 cases of IPD were reported within the surveillance programme in the Czech Republic, with 323 of these caused by serotype 19A. WGS data of the Czech serotype 19A isolates show a numerous and genetically related subpopulation of three sequencing types: ST-199, ST-416, and ST-3017. Within this subpopulation, the largest is the cluster of nine ST-199 isolates. High relatedness of ST-199 isolates is also confirmed by the fact that all but one isolate, 117/2019 (novel rST- -137805), share the same ribosome sequencing profile - rST-11365. Outside the above-mentioned subpopulation, there are only four isolates that form three separate genetic lines of serotype 19A. A highly similar situation is observed across European countries, where about half of all serotype 19A isolates form a genetically closely related subpopulation (ST-199, ST-416, ST-450, ST-667, ST-3017, and ST-10360) while isolates which are not part of this subpopulation represent a large number of unrelated genetic lines.

Conclusions: The study has shown a mostly homogeneous population of S. pneumoniae serotype 19A to circulate in the post-vaccination era in both the Czech Republic and Europe, with some unrelated isolates located outside this population.

目的:介绍19A型肺炎链球菌全基因组测序(WGS)分析结果,并与欧洲相关数据进行比较。19A血清型疫苗在捷克共和国广泛分布。材料和方法:WGS在本研究中被用作详细表征肺炎链球菌的最有效方法。对19株捷克分离株肺炎链球菌19A进行分析,并与PubMLST数据库中的415株欧洲分离株进行比较。结果:肺炎链球菌血清型19A可引起各种类型的病原体-宿主相互作用,从携带到非侵袭性和侵袭性肺炎球菌病(IPD)。2010 - 2019年,捷克共和国监测规划报告了3872例IPD病例,其中323例由血清型19A引起。捷克血清型19A分离株的WGS数据显示,三种测序类型ST-199、ST-416和ST-3017存在大量遗传相关的亚群。在这个亚群中,最大的是9个ST-199分离株。除了一株分离物117/2019(新rST- -137805)外,其他所有分离物都具有相同的核糖体测序谱- rST-11365,这一事实也证实了ST-199分离物的高亲缘性。在上述亚群之外,只有4个分离株形成3个独立的血清型19A遗传系。在欧洲各国也观察到高度相似的情况,在所有血清型19A分离株中,约有一半形成了遗传密切相关的亚群(ST-199、ST-416、ST-450、ST-667、ST-3017和ST-10360),而不属于该亚群的分离株则代表了大量不相关的遗传系。结论:该研究显示,接种疫苗后,在捷克共和国和欧洲,肺炎链球菌血清型19A在大多数同质人群中传播,一些不相关的分离株位于该人群之外。
{"title":"Population analysis of Streptococcus pneumoniae serotype 19A by whole genome sequencing in the Czech Republic and in Europe after serotype 19A inclusion in pneumococcal conjugate vaccine.","authors":"J Kozáková,&nbsp;Z Okonji,&nbsp;M Honskus","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Aim: </strong>To present the results of whole genome sequencing (WGS) analysis of Streptococcus pneumoniae serotype 19A and to compare them with the respective data from Europe. The vaccine serotype 19A is widely distributed in the Czech Republic.</p><p><strong>Material and methods: </strong>WGS was used in this study as the most powerful available method for detailed characterization of S. pneumoniae. Nineteen Czech isolates of S. pneumoniae 19A were analysed and compared with 415 European isolates included in the PubMLST database.</p><p><strong>Results: </strong>S. pneumoniae serotype 19A causes all types of pathogen - host interaction, from carriage to noninvasive and invasive pneumococcal disease (IPD). In 2010 - 2019, 3872 cases of IPD were reported within the surveillance programme in the Czech Republic, with 323 of these caused by serotype 19A. WGS data of the Czech serotype 19A isolates show a numerous and genetically related subpopulation of three sequencing types: ST-199, ST-416, and ST-3017. Within this subpopulation, the largest is the cluster of nine ST-199 isolates. High relatedness of ST-199 isolates is also confirmed by the fact that all but one isolate, 117/2019 (novel rST- -137805), share the same ribosome sequencing profile - rST-11365. Outside the above-mentioned subpopulation, there are only four isolates that form three separate genetic lines of serotype 19A. A highly similar situation is observed across European countries, where about half of all serotype 19A isolates form a genetically closely related subpopulation (ST-199, ST-416, ST-450, ST-667, ST-3017, and ST-10360) while isolates which are not part of this subpopulation represent a large number of unrelated genetic lines.</p><p><strong>Conclusions: </strong>The study has shown a mostly homogeneous population of S. pneumoniae serotype 19A to circulate in the post-vaccination era in both the Czech Republic and Europe, with some unrelated isolates located outside this population.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"70 2","pages":"110-117"},"PeriodicalIF":0.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39326987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-O1/non-O139 vibrios - occurrence not only in Europe in recent years. 非o1 /非o139弧菌——近年来不仅在欧洲出现。
IF 0.5 4区 医学 Q4 Medicine Pub Date : 2021-01-01
M Špačková, J Košťálová, K Fabiánová

Non-O1/non-O139 vibrios refer to all vibrios except toxin producing Vibrio cholerae serogroups O1 and O139. The prevalence of illness caused by non-O1/non-O139 vibrios steadily increases all over the world in the last 20 years, which is very probably related to global warming. These infections are reported year-round from tropical and subtropical climate zones, but they were also detected in the mild climate zone of the United States of America and Europe. In mild climate, they have markedly seasonal occurrence, typically peaking in May to October. A human can be infected after ingestion of contaminated food, especially seafood and fish, or water or while bathing. In Europe, non-O1/non-O139 vibrios were detected in the Baltic Sea, North Sea and Mediterranean Sea but also in ponds and rivers. Depending on the pathogen entry route, the clinical manifestation may appear as gastroenteritis, otitis, wound infection or severe up to fatal illness, predominantly in immunocompromised patients. There is no specific prevention. Non-specific prevention includes good personal and food handling hygiene practices and avoiding contact of unhealed wounds with sea or surface swimming water. Given the severity and increasing frequency of infections caused by non-O1/non-O139 vibrios, they should be considered in differential diagnosis of gastrointestinal and wound infections, especially in patients with a history of consumption of fish and seafood or with a history of contact of unhealed wounds with sea or other open swimming water.

非O1/非O139弧菌是指除产生毒素的霍乱弧菌O1和O139血清群外的所有弧菌。近20年来,由非o1 /非o139弧菌引起的疾病在全球范围内的患病率稳步上升,这很可能与全球变暖有关。这些感染在热带和亚热带气候区全年都有报告,但在美利坚合众国和欧洲的温和气候区也发现了这些感染。在气候温和的地区,它们有明显的季节性发生,通常在5月至10月达到高峰。人可能在摄入受污染的食物,特别是海鲜和鱼,或水或洗澡后被感染。在欧洲,波罗的海、北海和地中海以及池塘和河流中检测到非o1 /非o139弧菌。根据病原体进入途径的不同,临床表现可能表现为胃肠炎、中耳炎、伤口感染或严重到致命的疾病,主要发生在免疫功能低下的患者中。没有具体的预防措施。非特异性预防包括良好的个人和食品处理卫生习惯,避免未愈合的伤口接触海水或水面游泳水。鉴于非o1 /非o139弧菌引起的感染的严重程度和日益增加的频率,在胃肠道和伤口感染的鉴别诊断中应考虑它们,特别是对于有食用鱼类和海鲜史或有未愈合伤口与海洋或其他开放游泳水接触史的患者。
{"title":"Non-O1/non-O139 vibrios - occurrence not only in Europe in recent years.","authors":"M Špačková,&nbsp;J Košťálová,&nbsp;K Fabiánová","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Non-O1/non-O139 vibrios refer to all vibrios except toxin producing Vibrio cholerae serogroups O1 and O139. The prevalence of illness caused by non-O1/non-O139 vibrios steadily increases all over the world in the last 20 years, which is very probably related to global warming. These infections are reported year-round from tropical and subtropical climate zones, but they were also detected in the mild climate zone of the United States of America and Europe. In mild climate, they have markedly seasonal occurrence, typically peaking in May to October. A human can be infected after ingestion of contaminated food, especially seafood and fish, or water or while bathing. In Europe, non-O1/non-O139 vibrios were detected in the Baltic Sea, North Sea and Mediterranean Sea but also in ponds and rivers. Depending on the pathogen entry route, the clinical manifestation may appear as gastroenteritis, otitis, wound infection or severe up to fatal illness, predominantly in immunocompromised patients. There is no specific prevention. Non-specific prevention includes good personal and food handling hygiene practices and avoiding contact of unhealed wounds with sea or surface swimming water. Given the severity and increasing frequency of infections caused by non-O1/non-O139 vibrios, they should be considered in differential diagnosis of gastrointestinal and wound infections, especially in patients with a history of consumption of fish and seafood or with a history of contact of unhealed wounds with sea or other open swimming water.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"70 2","pages":"131-138"},"PeriodicalIF":0.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39326989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk of latent tuberculosis in the cohort of patients with rheumatoid arthritis in Slovakia. 斯洛伐克类风湿关节炎患者队列中潜伏结核的风险。
IF 0.5 4区 医学 Q4 Medicine Pub Date : 2021-01-01
J Malinová, M Hájková, A Hatalová, E Šteňová

Aim: This study aims to determine the prevalence of latent tuberculosis infection (LTBI) in patients with moderate to severe rheumatoid arthritis (RA) who receive conventional and anti-cytokine therapy, to identify possible risk factors for tuberculosis (TB) and to evaluate the prophylactic treatment in positively screened patients.

Patient and methods: We conducted an observational, retrospective study in patients with RA, who underwent LTBI screening (chest X-ray, tuberculin skin test and interferon gamma release assay test - IGRA test).

Results: Out of 124 patients included, 7.25% of patients were diagnosed with LTBI during the treatment with conventional synthetic anti-rheumatic drugs in combination with glucocorticoids before initiation of anti-cytokine therapy. Another 21.77% were diagnosed during treatment with biologics or Janus kinase inhibitors. We confirmed the highest incidence of LTBI in TNF-treated group (66.66% LTBI positive patients), but also found positive screening in patients treated with other modalities. The mean LTBI detection time since the initiation of anti-cytokine therapy was 39.5 months (12-134 months). Active TB with clinical manifestation has occurred in one patient. Statistical analysis did not show an association between risk of LTBI and age, sex or treatment modality.

Conclusion: The results of this study confirm the necessity of LTBI screening and long-term monitoring in RA patients treated with any kind of anti-cytokine therapy. The currently used national recommendations are sufficiently sensitive to identify TB in these patients. There remains a question of screening and prophylactic antituberculosis therapy in patients treated with conventional synthetic anti-rheumatic drugs in combination with glucocorticoids.

目的:本研究旨在确定接受常规和抗细胞因子治疗的中重度类风湿关节炎(RA)患者的潜伏性结核感染(LTBI)患病率,确定结核病(TB)可能的危险因素,并评估筛查阳性患者的预防性治疗。患者和方法:我们对接受LTBI筛查(胸部x线、结核菌素皮肤试验和干扰素γ释放试验- IGRA试验)的RA患者进行了一项观察性、回顾性研究。结果:124例患者中,在开始抗细胞因子治疗前,在常规合成抗风湿药物联合糖皮质激素治疗期间诊断为LTBI的患者占7.25%。另有21.77%的患者是在使用生物制剂或Janus激酶抑制剂治疗期间确诊的。我们证实tnf治疗组LTBI发生率最高(66.66% LTBI阳性患者),但也发现其他方式治疗的患者筛查呈阳性。自抗细胞因子治疗开始以来,LTBI平均检测时间为39.5个月(12-134个月)。1例患者出现有临床表现的活动性结核。统计分析没有显示LTBI风险与年龄、性别或治疗方式之间的关联。结论:本研究结果证实了在接受任何一种抗细胞因子治疗的RA患者中进行LTBI筛查和长期监测的必要性。目前使用的国家建议足够敏感,可识别这些患者中的结核病。在常规合成抗风湿药物与糖皮质激素联合治疗的患者中,筛查和预防性抗结核治疗仍然是一个问题。
{"title":"Risk of latent tuberculosis in the cohort of patients with rheumatoid arthritis in Slovakia.","authors":"J Malinová,&nbsp;M Hájková,&nbsp;A Hatalová,&nbsp;E Šteňová","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Aim: </strong>This study aims to determine the prevalence of latent tuberculosis infection (LTBI) in patients with moderate to severe rheumatoid arthritis (RA) who receive conventional and anti-cytokine therapy, to identify possible risk factors for tuberculosis (TB) and to evaluate the prophylactic treatment in positively screened patients.</p><p><strong>Patient and methods: </strong>We conducted an observational, retrospective study in patients with RA, who underwent LTBI screening (chest X-ray, tuberculin skin test and interferon gamma release assay test - IGRA test).</p><p><strong>Results: </strong>Out of 124 patients included, 7.25% of patients were diagnosed with LTBI during the treatment with conventional synthetic anti-rheumatic drugs in combination with glucocorticoids before initiation of anti-cytokine therapy. Another 21.77% were diagnosed during treatment with biologics or Janus kinase inhibitors. We confirmed the highest incidence of LTBI in TNF-treated group (66.66% LTBI positive patients), but also found positive screening in patients treated with other modalities. The mean LTBI detection time since the initiation of anti-cytokine therapy was 39.5 months (12-134 months). Active TB with clinical manifestation has occurred in one patient. Statistical analysis did not show an association between risk of LTBI and age, sex or treatment modality.</p><p><strong>Conclusion: </strong>The results of this study confirm the necessity of LTBI screening and long-term monitoring in RA patients treated with any kind of anti-cytokine therapy. The currently used national recommendations are sufficiently sensitive to identify TB in these patients. There remains a question of screening and prophylactic antituberculosis therapy in patients treated with conventional synthetic anti-rheumatic drugs in combination with glucocorticoids.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"70 2","pages":"83-90"},"PeriodicalIF":0.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39328097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Epidemiologie Mikrobiologie Imunologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1